CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional paid-in capital	Retained earnings	Treasury stock	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023		4,518,848
Beginning balances at Dec. 31, 2023	$ 65,807	$ 9,991	$ 2,621	$ 89,472	$ (4,322)	$ (31,955)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,436			4,436
Other comprehensive income (loss)	(3,268)					(3,268)
Dividend reinvestment plan (in shares)		1,147
Dividend reinvestment plan	33		23		10
Cash dividends declared	(3,254)			(3,254)
Stock based compensation expense (in shares)		3,872
Stock based compensation expense	292	$ 8	284
Ending balance (in shares) at Jun. 30, 2024		4,523,867
Ending balances at Jun. 30, 2024	64,046	$ 9,999	2,928	90,654	(4,312)	(35,223)
Beginning balance (in shares) at Mar. 31, 2024		4,519,388
Beginning balances at Mar. 31, 2024	63,820	$ 9,991	2,778	90,262	(4,317)	(34,894)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,019			2,019
Other comprehensive income (loss)	(329)					(329)
Dividend reinvestment plan (in shares)		607
Dividend reinvestment plan	17		12		5
Cash dividends declared	(1,627)			(1,627)
Stock based compensation expense (in shares)		3,872
Stock based compensation expense	146	$ 8	138
Ending balance (in shares) at Jun. 30, 2024		4,523,867
Ending balances at Jun. 30, 2024	64,046	$ 9,999	2,928	90,654	(4,312)	(35,223)
Beginning balance (in shares) at Dec. 31, 2024		4,538,009
Beginning balances at Dec. 31, 2024	66,480	$ 10,024	3,031	91,722	(4,300)	(33,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,896			4,896
Other comprehensive income (loss)	2,766					2,766
Dividend reinvestment plan (in shares)		1,153
Dividend reinvestment plan	36		26		10
Cash dividends declared	(3,268)			(3,268)
Stock based compensation expense (in shares)		3,736
Stock based compensation expense	296	$ 8	288
Common stock issued, net of issuance costs (in shares)		8,437
Common stock issued, net of issuance costs	52	$ 17	35
Ending balance (in shares) at Jun. 30, 2025		4,551,335
Ending balances at Jun. 30, 2025	71,258	$ 10,049	3,380	93,350	(4,290)	(31,231)
Beginning balance (in shares) at Mar. 31, 2025		4,538,598
Beginning balances at Mar. 31, 2025	70,074	$ 10,024	3,190	92,589	(4,295)	(31,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,395			2,395
Other comprehensive income (loss)	203					203
Dividend reinvestment plan (in shares)		564
Dividend reinvestment plan	18		13		5
Cash dividends declared	(1,634)			(1,634)
Stock based compensation expense (in shares)		3,736
Stock based compensation expense	150	$ 8	142
Common stock issued, net of issuance costs (in shares)		8,437
Common stock issued, net of issuance costs	52	$ 17	35
Ending balance (in shares) at Jun. 30, 2025		4,551,335
Ending balances at Jun. 30, 2025	$ 71,258	$ 10,049	$ 3,380	$ 93,350	$ (4,290)	$ (31,231)